Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Significance of Membrane Transport01:44

The Significance of Membrane Transport

40.5K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
40.5K
Facilitated Transport01:19

Facilitated Transport

145.0K
The chemical and physical properties of plasma membranes cause them to be selectively permeable. Since plasma membranes have both hydrophobic and hydrophilic regions, substances need to be able to transverse both regions. The hydrophobic area of membranes repels substances such as charged ions. Therefore, such substances need special membrane proteins to cross a membrane successfully. In  facilitated transport, also known as facilitated diffusion, molecules and ions travel across a...
145.0K
Facilitated Transport01:19

Facilitated Transport

17.8K
The chemical and physical properties of plasma membranes cause them to be selectively permeable. Since plasma membranes have both hydrophobic and hydrophilic regions, substances need to be able to transverse both regions. The hydrophobic area of membranes repels substances such as charged ions. Therefore, such substances need special membrane proteins to cross a membrane successfully. In  facilitated transport, also known as facilitated diffusion, molecules and ions travel across a...
17.8K
Facilitated Diffusion01:16

Facilitated Diffusion

1.0K
The plasma membrane, a critical structure in cellular biology, houses an array of transporters, or carrier proteins, interspersed within its lipid bilayer. These proteins play a crucial role in solute transport through facilitated diffusion, a form of passive diffusion that uses transporters to move the molecules across the membrane.
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
1.0K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

864
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
864
Membrane Transporters01:31

Membrane Transporters

17.4K
Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
17.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A clinically relevant reinterpretation of disk approximation testing for inducible AmpC in <i>Pseudomonas aeruginosa</i>.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2025
Same author

Clinical and economic burden of herpes zoster in Mexico: A retrospective medical chart analysis in a private healthcare setting.

Human vaccines & immunotherapeutics·2025
Same author

Persistence of COVID-19 Symptoms and Quality of Life at Three and Twelve Months after Hospital Discharge.

Medicina (Kaunas, Lithuania)·2024
Same author

Association between phenotypic characteristics of Escherichia coli and UTI recurrence in immunocompromised patients: A case-control study.

American journal of infection control·2023
Same author

Oral colonization by gram-negative bacilli in patients with hematologic malignancies and solid tumors compared with healthy controls.

BMC oral health·2023
Same author

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico.

NPJ vaccines·2023

Related Experiment Video

Updated: Dec 15, 2025

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems
06:18

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems

Published on: April 26, 2019

6.3K

Transfer Factor: Myths and Facts.

Alejandro E Macias1, Eduardo Guaní-Guerra2

  • 1Departamento de Medicina, Universidad de Guanajuato, Guanajuato, México.

Archives of Medical Research
|July 14, 2020
PubMed
Summary

Transfer factor (TF) is a leukocyte extract used to transfer immunity, modulating cell-mediated responses. Its exact nature and optimal use remain unclear, despite varied clinical applications.

Keywords:
Cell-mediated immunityDialyzable leukocyte extractImmunostimulantsLawrence transfer factorTransfer factor

More Related Videos

Split-Ubiquitin Based Membrane Yeast Two-Hybrid MYTH System: A Powerful Tool For Identifying Protein-Protein Interactions
14:04

Split-Ubiquitin Based Membrane Yeast Two-Hybrid MYTH System: A Powerful Tool For Identifying Protein-Protein Interactions

Published on: February 1, 2010

31.7K
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.1K

Related Experiment Videos

Last Updated: Dec 15, 2025

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems
06:18

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems

Published on: April 26, 2019

6.3K
Split-Ubiquitin Based Membrane Yeast Two-Hybrid MYTH System: A Powerful Tool For Identifying Protein-Protein Interactions
14:04

Split-Ubiquitin Based Membrane Yeast Two-Hybrid MYTH System: A Powerful Tool For Identifying Protein-Protein Interactions

Published on: February 1, 2010

31.7K
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
03:53

Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis

Published on: December 29, 2023

1.1K

Area of Science:

  • Immunology
  • Cellular Biology

Background:

  • Transfer factor (TF), also known as dialyzable leukocyte extract (DLE), has been utilized since the mid-20th century for transferring specific skin hypersensitivity.
  • It is derived from leukocytes of immunized donors and administered to recipients.

Purpose of the Study:

  • To review the current understanding of Transfer Factor (TF).
  • To elucidate its mechanism of action, production, biological effects, and clinical trial data.
  • To define its potential role in modern medicine.

Main Methods:

  • Literature review of existing studies on Transfer Factor (TF).
  • Analysis of TF's proposed mechanisms, including effects on cytokines like MIF, IFN-γ, TNF-α, and IL-4, and pathways like NF-κB.
  • Examination of diverse clinical trial outcomes for various conditions.

Main Results:

  • TF modulates cell-mediated immunity by inducing MIF and IFN-γ production.
  • TF can inhibit NF-κB, decreasing TNF-α and IL-4 levels.
  • Clinical applications in infections, allergies, autoimmunity, and cancer show inconsistent results.

Conclusions:

  • The precise nature of TF remains undefined, complicating pharmacokinetic and dosage determinations.
  • Variability in TF research (antigen-specific vs. non-specific, administration routes, origin) contributes to inconsistent findings.
  • Further research is needed to establish TF's precise role and optimize its clinical application.